Biomerica Inc (BMRA) stock
BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3047% below fair value
$1.32−0.04 (-2.94%)
Close on Nov 16, 2026Market cap $6.07MP/E –Yield –
Biomerica EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Biomerica's EV/EBITDA was 15.1× on Dec 31, 2013, against 5.2× a year earlier. Over the last 2 years it ranged from 4.7× to 20.0×, with a median of 6.9×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2013 | Dec 31, 2013 | 15.1× | +9.9 |
| 2012 | Dec 31, 2012 | 5.2× | −12.3 |
| 2011 | Dec 30, 2011 | 17.5× | – |
See a number that looks wrong?